Showing results (21-30 of 158) with videos related to

Sort By:
Pageof 16
Journal of Neuro-Oncology|June 18, 2010
Can high-dose fotemustine reverse MGMT resistance in glioblastoma multiforme?Chiara Gallo, Carlo Buonerba, Giuseppe Di Lorenzo, et al.
World Journal of Clinical Cases|December 5, 2013
Long lasting response to second-line everolimus in kidney cancerAntonella Virtuoso, Tania Policastro, Michela Izzo, et al.
Medicine|February 5, 2016
Complete Response and Fatigue Improvement With the Combined Use of Cyclophosphamide and Quercetin in a Patient With Metastatic Bladder Cancer: A Case ReportGiuseppe Di Lorenzo, Martina Pagliuca, Teresa Perillo, et al.
Medicine|April 9, 2016
Docetaxel Rechallenge in a Heavily Pretreated Patient With Castration-Resistant Prostate Cancer: A Case Report and Review of LiteratureGiuseppe Di Lorenzo, Martina Pagliuca, Teresa Perillo, et al.
World Journal of Clinical Oncology|July 13, 2012
Everolimus plus long-acting somatostatin analogs in thymic epithelial malignanciesGiovannella Palmieri, Carlo Buonerba, Piera Federico, et al.
Polish Journal of Radiology|January 17, 2015
Correlative Imaging in a Patient with Cystic Thymoma: CT, MR and PET/CT ComparisonValeria Romeo, Alfredo Esposito, Simone Maurea, et al.
Frontiers in Oncology|September 28, 2020
Perspective: Cancer Patient Management Challenges During the COVID-19 PandemicDaniela Terracciano, Carlo Buonerba, Luca Scafuri, et al.
Medicine|July 7, 2018
High-dose fotemustine in temozolomide-pretreated glioblastoma multiforme patients: A phase I/II trialAlfredo Marinelli, Giuseppe Lamberti, Luigi Cerbone, et al.
Molecules (Basel, Switzerland)|November 9, 2024
Synergistic Combination of Quercetin and Mafosfamide in Treatment of Bladder Cancer CellsCarmela Spagnuolo, Francesco Mautone, Anna Maria Iole Meola, et al.
Expert Opinion on Biological Therapy|December 16, 2014
The epidermal growth factor receptors as biological targets in penile cancerGiuseppe Di Lorenzo, Carlo Buonerba, Matteo Ferro, et al.
Pageof 16